MRTX - MRTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Mirati Therapeutics Inc. to Bristol Myers Squibb | Benzinga
MONSEY, N.Y., Oct. 20, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Mirati Therapeutics, Inc. (NASDAQ:MRTX) ("Mirati") to Bristol Myers Squibb ("Bristol Myers") for $58.00 per share in cash, plus a contingent value right (CVR) potentially worth an additional $12.00 per share in cash.
If you remain a Mirati shareholder and have concerns about the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge:
https://wohlfruchter.com/cases/mirati-therapeutics-inc/
Alternatively, you may contact us by phone at 866-833-6245, ...